- Home
- PMVP vs FORA Comparison
PMVP vs FORA Comparison
Compare PMVP & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- FORA
- Stock Information
- Founded
- PMVP 2013
- FORA 2014
- Country
- PMVP United States
- FORA United States
- Employees
- PMVP N/A
- FORA N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- FORA Computer Software: Prepackaged Software
- Sector
- PMVP Health Care
- FORA Technology
- Exchange
- PMVP Nasdaq
- FORA Nasdaq
- Market Cap
- PMVP 77.4M
- FORA 60.2M
- IPO Year
- PMVP 2020
- FORA N/A
- Fundamental
- Price
- PMVP $1.20
- FORA $2.23
- Analyst Decision
- PMVP Strong Buy
- FORA Strong Buy
- Analyst Count
- PMVP 1
- FORA 1
- Target Price
- PMVP $5.00
- FORA $5.00
- AVG Volume (30 Days)
- PMVP 2.6M
- FORA 74.8K
- Earning Date
- PMVP 11-06-2025
- FORA 11-12-2025
- Dividend Yield
- PMVP N/A
- FORA N/A
- EPS Growth
- PMVP N/A
- FORA N/A
- EPS
- PMVP N/A
- FORA N/A
- Revenue
- PMVP N/A
- FORA $25,031,040.00
- Revenue This Year
- PMVP N/A
- FORA $47.82
- Revenue Next Year
- PMVP N/A
- FORA $10.11
- P/E Ratio
- PMVP N/A
- FORA N/A
- Revenue Growth
- PMVP N/A
- FORA 18.59
- 52 Week Low
- PMVP $0.81
- FORA $1.64
- 52 Week High
- PMVP $1.84
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- PMVP 40.25
- FORA 58.98
- Support Level
- PMVP $1.19
- FORA $2.20
- Resistance Level
- PMVP $1.40
- FORA $2.39
- Average True Range (ATR)
- PMVP 0.16
- FORA 0.13
- MACD
- PMVP -0.04
- FORA 0.02
- Stochastic Oscillator
- PMVP 10.95
- FORA 68.63
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.